Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label 12-Week Food Study to Assess the Safety, Tolerability, And Physiological Effects of An Amino Acid Food Product, AXA4010, In Subjects With Sickle Cell Disease.

NCT04134299 is registered in ClinicalTrials.gov with Axcella Health, Inc as lead sponsor.

NCT NCT04134299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04134299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label 12-Week Food Study to Assess the Safety, Tolerability, And Physiological Effects of An Amino Acid Food Product, AXA4010, In Subjects With Sickle Cell Disease.
Lead sponsor
Axcella Health, Inc
Phase
Not applicable
Overall status
Completed
Start date
September 25, 2019
Completion date
January 11, 2021
Enrollment
9 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, sickle cell, sickle cell anemia, sickle cell disease, sickle cell disorders, to assess the safety and tolerabiltiy of an amino acid composition in subjects with sickle cell disease